Skip to main content
Journal ArticleOPEN ACCESS

Biosimilars: what are they and why do we need to know?

  • Chaplin S
Prescriber (2014) 25(23-24) 40-42
DOI: 10.1002/psb.1292
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

As several widely used biological agents are due to come off patient the market for biosimilars is likely to grow. Here we analyse the implications for primary care

Cite

CITATION STYLE

APA

Chaplin, S. (2014). Biosimilars: what are they and why do we need to know? Prescriber, 25(23–24), 40–42. https://doi.org/10.1002/psb.1292

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free